Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 5019 (107th)

Medicare Rx Drug Benefit and Discount Act of 2002

referredUnited States· United States Congress· EN

Introduced

26 June 2002

Last action

16 July 2002 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Rangel, Charles B. [D-NY-15], Rep. Dingell, John D. [D-MI-12], Rep. Holden, Tim [D-PA-17], Rep. Maloney, James H. [D-CT-5], Rep. Ross, Mike [D-AR-4], Rep. Shows, Ronnie [D-MS-4], Sen. Brown, Sherrod [D-OH], Rep. Stark, Fortney Pete [D-CA-13], Rep. Waxman, Henry A. [D-CA-33], Rep. Pallone, Frank [D-NJ-6], Rep. Abercrombie, Neil [D-HI-1], Rep. Ackerman, Gary L. [D-NY-5], Rep. Allen, Thomas H. [D-ME-1], Rep. Andrews, Robert E. [D-NJ-1], Rep. Baca, Joe [D-CA-43], Rep. Baird, Brian [D-WA-3], Rep. Baldacci, John Elias [D-ME-2], Sen. Baldwin, Tammy [D-WI], Rep. Barcia, James A. [D-MI-5], Rep. Barrett, Thomas M. [D-WI-5], Rep. Becerra, Xavier [D-CA-34], Rep. Berkley, Shelley [D-NV-1], Rep. Berry, Marion [D-AR-1], Rep. Blumenauer, Earl [D-OR-3], Rep. Bonior, David E. [D-MI-10], Rep. Borski, Robert A. [D-PA-3], Rep. Boswell, Leonard L. [D-IA-3], Rep. Boucher, Rick [D-VA-9], Rep. Capps, Lois [D-CA-24], Rep. Capuano, Michael E. [D-MA-8], Sen. Cardin, Benjamin L. [D-MD], Rep. Carson, Julia [D-IN-7], Del. Christensen, Donna M. [D-VI-At Large], Rep. Clay, Wm. Lacy [D-MO-1], Rep. Conyers, John, Jr. [D-MI-13], Rep. Coyne, William J. [D-PA-14], Rep. Crowley, Joseph [D-NY-14], Rep. Cummings, Elijah E. [D-MD-7], Rep. Davis, Danny K. [D-IL-7], Rep. DeGette, Diana [D-CO-1], Rep. Delahunt, William D. [D-MA-10], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Deutsch, Peter [D-FL-20], Rep. Doyle, Michael F. [D-PA-14], Rep. Engel, Eliot L. [D-NY-16], Rep. Eshoo, Anna G. [D-CA-18], Rep. Evans, Lane [D-IL-17], Rep. Filner, Bob [D-CA-51]

Subjects

Healthcare, Defence, Education

Source updated

19 August 2025

Healthcare · Defence · Education

Summary

Medicare Modernization and Prescription Drug Act of 2002 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to add a new part D (Voluntary Prescription Drug Benefit Program) under which each individual who is entitled to benefits under Medicare part A (Hospital Insurance) or eligible to enroll under Medicare part B (Supplemental Medical Insurance) is entitled to obtain qualified prescription drug coverage. Outlines standard coverage benefit packages for FY 2005. Includes for the standard package a monthly premium of $25, an annual deductible of $100, a coinsurance of 20 percent and an annual out-of-pocket spending limit of $2,000. Directs the Secretary to negotiate fair prices with pharmaceutical manufacturers. Provides for accelerated generic drug competition. Amends SSA title XVIII part C (Medicare+Choice) with respect to: (1) inclusion of the costs of certain military services to Medicare-eligible beneficiaries in the calculation of Medicare+Choice payment rates; (2) specialized Medicare+Choice plans for special needs beneficiaries; and (3) continuous open enrollment and disenrollment at any time. Revises requirements for Medicare: (1) part A concerning rural health care, inpatient hospital services, skilled nursing facility services, and hospices; (2) part B concerning physicians services and other services; and (3) part A and B concerning home health services and direct graduate medical education. Amends SSA title XIX (Medicaid) with respect to certain Medicaid disproportionate share hospital (DSH) allotment adjustments and the Q-I1 program. Amends the Federal Food, Drug, and Cosmetic Act to add requirements for interstate Internet sellers of prescription drugs. Establishes within the Office of the Director of the National Institutes of Health the Office of Rare Diseases. Amends the Public Health Services Act with respect to promotion of the pharmacist profession.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 26 June 2002

    Introduced

    Referred, pursuant to the order of the House of June 17, 2002, jointly to the Committees on Energy and Commerce and Ways and Means.

    Source: IntroReferral

  2. 26 June 2002

    Introduced

    Referred, pursuant to the order of the House of June 17, 2002, jointly to the Committees on Energy and Commerce and Ways and Means.

    Source: IntroReferral

  3. 26 June 2002

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 26 June 2002

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 27 June 2002

    Introduced

    Sponsor introductory remarks on measure. (CR E1161)

    Source: IntroReferral

  6. 16 July 2002

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 26 June 2002

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 26 June 2002

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 26 June 2002

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 144 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.